Please login to the form below

Not currently logged in
Email:
Password:

UK launches stem cell centre

King's College London is to set up a centre for stem cell and regenerative medicine

King's College London is set to launch the Centre for Stem Cells and regenerative medicine.

The centre, which will be based at Guy's Hospital in London, will bring together the cutting-edge stem cell research currently taking place across the College and its partner NHS trusts, as part of King's Health Partners. King's hopes to drive collaboration between scientists and clinicians through the centre, to translate the potential of stem cells into clinical reality for patients.

Professor Robert Lechler, vice-principal for Health at King's and executive director of King's Health Partners, said: "Our work at King's Health Partners, an Academic Health Sciences Centre, is focused on translating scientific research into clinical treatments for patients much faster. As the use of stem cells in regenerative medicine is emerging as a key priority for research in the UK, I am excited about what we can achieve through the Centre for Stem Cells & Regenerative Medicine at King's."

Professor Fiona Watt, former president of the International Society of Stem Cell Research, has been appointed as director of the centre, and from January 2012 will co-ordinate existing stem cell research at King's as well as establish her own research programme.

14th June 2011

From: Healthcare

Share

Subscribe to our email news alerts

PMHub

Add my company
Kardex

Kardex is a global industry partner for intralogistics solutions and a leading supplier of automated storage solutions and material handling...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....